MIM
BLUE

Monashee Investment Management’s bluebird bio BLUE Stock Holding History

Monashee Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,000
Closed -$690K – 109
2023
Q4 		$690K Buy
+25,000
New +$1.52M 0.12% 38
2020
Q3 		– Sell
-10,036
Closed -$7.93M – 185
2020
Q2 		$7.93M Buy
+10,036
New +$7.57M 1.19% 14
2017
Q4 		– Hold
0
– – – 13
2017
Q3 		– Sell
-9,650
Closed -$13.1M – 90
2017
Q2 		$13.1M Buy
+9,650
New +$11.6M 5.55% 2

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Monashee Investment Management's BLUE Position: Q1 2024 in Review

Monashee Investment Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 25,000 shares — an estimated $690K sold.

Monashee Investment Management first reported a position in BLUE in Q2 2017 and held it in 3 quarters. The position peaked at $13.1M in Q2 2017. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Monashee Investment Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Monashee Investment Management sold 25,000 bluebird bio shares in Q1 2024, an estimated $690K.
  • Monashee Investment Management first reported a position in bluebird bio in Q2 2017 and held it in 3 quarters.
  • Monashee Investment Management's bluebird bio position peaked at $13.1M in Q2 2017.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Monashee Investment Management's 13F filing for Q1 2024, filed 14 May 2024.